Round Type
Series B
New YorkHealthcareHealth CareDescription
Spine BioPharma, Inc., a biopharmaceutical company committed to developing non-opiate, non-surgical therapies for the treatment of pain and disability from chronic low back pain caused by degenerative disc disease, today announced the completion of a $13 million Series B equity financing. Existing investors Viscogliosi Bros., LLC, Cercano Management, Pacira Biosciences and others participated in the financing. The company intends to use the financing to support further development of SB-01 For Injection "SB-01" (formerly referred to as RemediscTM), a first-in-class therapeutic for the treatment of degenerative disc disease.
Quick answer
Spine BioPharma raised an undisclosed amount in a Series B round, dated March 28, 2022. Spine BioPharma is based in New York, New York, United States.
- How much did Spine BioPharma raise?
- Spine BioPharma raised an undisclosed amount in a Series B round on March 28, 2022.
- What does Spine BioPharma do?
- Patients around the world are struggling with debilitating back pain, trying to avoid invasive surgeries and the potential of opioid addiction.
- Where is Spine BioPharma based and how big is it?
- Spine BioPharma is based in New York, New York, United States.
- Who are the decision-makers at Spine BioPharma?
- Fundz holds 2 contacts at Spine BioPharma, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Spine BioPharma, and when
A new round usually means Spine BioPharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Spine BioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Spine BioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Spine BioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Spine BioPharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSpine BioPharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.